Rep. Rush Reintroduces Bill Requiring Drug Companies to Properly Label Products That Present an Increased Risk of Suicide or Depression
September 19, 2019
September 19, 2019
WASHINGTON, Sept. 19 -- Rep. Bobby Rush, D-Illinois, issued the following news release:
Today, U.S. Representative Bobby L. Rush (D-Ill.) reintroduced an important piece of legislation that would require drug companies to properly label products that present an increased risk of suicide or depression as a side effect.
The Depression Effect Labeling Awareness Act of 2019 (H.R. 4404) was originally introduced last year by Rep. Rush and would amend the Federal Food, Drug, . . .
Today, U.S. Representative Bobby L. Rush (D-Ill.) reintroduced an important piece of legislation that would require drug companies to properly label products that present an increased risk of suicide or depression as a side effect.
The Depression Effect Labeling Awareness Act of 2019 (H.R. 4404) was originally introduced last year by Rep. Rush and would amend the Federal Food, Drug, . . .